Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results

Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) technology, today announced successful treatment of the first patient in its randomized, double‑blinded U.S. pilot clinical trial for uncontrolled hypertension. This milestone accelerates the company’s mission to commercialize a novel, targeted, minimally invasive therapy to address the global burden of high blood pressure. The RPD […]